Alnylam Pharmaceuticals,  —

Recent Posts

• My porphyria diagnosis began with mood swings, pain, and nausea
• Poorer physical, social quality of life found for EPP children in study
• Neurofilament light, nerve damage marker, high in AHP patients
• New AI algorithm scans patient records to find undiagnosed AHP
• Iron supplements may cause side effects for EPP patients
• The unseen battles: Advocating for mental health in the porphyrias
• Scenesse may gain orphan drug status for variegate porphyria in EU
• Rare mutation causing hereditary iron disorder leads to PCT: Report
• Risk factors, effective treatments for PCT identified in study